Soluble Endoglin Level Increase Occurs Prior to Development of Subclinical Structural Vascular Alterations in Diabetic Adolescents

Autor: Cagri Damar, Peyami Cinaz, Nurullah Çelik, Betül Emine Derinkuyu, Esra Doger, Mahmut Orhun Çamurdan, Aysun Bideci, Hamdi Cihan Emeksiz, Mehmet Cuneyt Ozmen, Özge Yüce
Rok vydání: 2016
Předmět:
Male
medicine.medical_specialty
Adolescent
Brachial Artery
subclinical atherosclerosis
Endocrinology
Diabetes and Metabolism

030209 endocrinology & metabolism
030204 cardiovascular system & hematology
Diabetic angiopathy
Nitric Oxide
Carotid Intima-Media Thickness
03 medical and health sciences
0302 clinical medicine
Endocrinology
hemic and lymphatic diseases
Diabetes mellitus
Internal medicine
otorhinolaryngologic diseases
medicine
Albuminuria
Humans
adolescents
Endothelial dysfunction
Subclinical infection
Analysis of Variance
Type 1 diabetes
business.industry
Endoglin
medicine.disease
Cross-Sectional Studies
Diabetes Mellitus
Type 1

Solubility
Intima-media thickness
Pediatrics
Perinatology and Child Health

Original Article
Female
Microalbuminuria
Endothelium
Vascular

medicine.symptom
business
soluble endoglin
type 1 diabetes mellitus
Biomarkers
Blood Flow Velocity
Diabetic Angiopathies
Dilatation
Pathologic
Zdroj: Journal of Clinical Research in Pediatric Endocrinology
ISSN: 1308-5727
Popis: Objective: Soluble endoglin (S-endoglin) has been implicated as a potential marker of endothelial dysfunction (ED) and was reported to be elevated in diabetic adults, correlating with the severity of diabetic vasculopathy. However, circulating S-endoglin and its association with other markers of ED have not been formerly analyzed in the first decade of diabetes onset in adolescents with type 1 diabetes mellitus (T1DM). Methods: Fifty-eight adolescents with moderately/poorly controlled T1DM were included in this study and twenty-nine healthy adolescents served as controls. The diabetic group was divided into two groups based on the presence of microalbuminuria, as the microalbuminuria group (n=15) and the normoalbuminuria group (n=43). Functional vascular alterations were evaluated by measuring serum S-endoglin and plasma nitric oxide (NO) concentrations, the flow-mediated dilatation (FMD) of the brachial artery. Carotid intima media thickness (CIMT) was measured for evaluation of structural vascular alterations. Results: The S-endoglin and NO levels of both microalbuminuria and normoalbuminuria groups were higher than those of the control group (for S-endoglin, p=0.047 and p
Databáze: OpenAIRE